THE INTERNATIONAL LIVER CONGRESS
Lugar: Amsterdam, Holanda
Fecha: 19-23 de abril
Asistentes: Pablo Ortiz, Azucena Castro, Cristina Alonso, Rebeca Mayo, Miriam Pérez
Posters:
COMPREHENSIVE NAFLD DIAGNOSIS BASED ON A NONINVASIVE METABOLOMIC APPROACH IN A LIQUID BIOPSY
Abstract SAT-488; sábado 22 abril; 08:00 - 18:00
Sesión: Non-invasive assessment of liver disease
Autor principal: José M Mato
Presentador: Puneet Puri
ARAMCHOL REDUCES ESTABLISHED FIBROSIS IN MCD DIET ANIMAL MODEL
Abstract FRI-358; viernes 21 abril; 08:00 - 18:00
Sesión: Fatty liver disease: Experimental and pathophysiology
Autor principal y presentador: José M Mato
NONINVASIVE SERUM BIOMARKERS REFLECT THE EFFECT OF ARAMCHOL ON MICE FIBROTIC LIVERS
Abstract SAT-330; sábado 22 abril; 08:00 - 18:00
Sesión: Fatty liver disease: Experimental and pathophysiology
Autor principal y presentador: José M Mato
Mini workshop: NASH in the spotlight: a metabolomics approach
Moderadores: Pierre Bedossa, MD, PhD, Catedrático de patología en la Universidad Paris-Diderot, Francia & José M Mato, Catedrático y Director General, CIC bioGUNE y CIC biomaGUNE, España
NASH activity: non-invasive patient selection for clinical trials
Ponente: Pablo Ortiz, MD, PhD, OWL Metabolomics, Spain
NASH diagnosis in type 2 diabetes mellitus
Ponente: Miriam Pérez, OWL Metabolomics, Spain
The impact of bariatric surgery on NAFLD
Ponente: Carmit Netanel, APD, Liver Disease Center, Sheba Medical Center, Israel
HTTPS://ILC-CONGRESS.EU/